OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 153 filers reported holding OCULAR THERAPEUTIX INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $180,330 | -28.9% | 26,364 | -5.4% | 0.00% | – |
Q1 2024 | $253,708 | +159.1% | 27,880 | +27.0% | 0.00% | – |
Q4 2023 | $97,937 | +41.3% | 21,959 | -0.5% | 0.00% | – |
Q3 2023 | $69,303 | -39.6% | 22,071 | -0.8% | 0.00% | – |
Q2 2023 | $114,789 | -4.8% | 22,246 | -2.7% | 0.00% | – |
Q1 2023 | $120,530 | +74.6% | 22,871 | -6.9% | 0.00% | – |
Q4 2022 | $69,030 | -17.8% | 24,566 | +22.2% | 0.00% | – |
Q3 2022 | $84,000 | +1.2% | 20,095 | -2.3% | 0.00% | – |
Q2 2022 | $83,000 | +20.3% | 20,571 | +46.6% | 0.00% | – |
Q1 2022 | $69,000 | -24.2% | 14,035 | +7.7% | 0.00% | – |
Q4 2021 | $91,000 | -93.8% | 13,036 | -91.1% | 0.00% | -100.0% |
Q3 2021 | $1,458,000 | -29.2% | 145,741 | +0.4% | 0.00% | 0.0% |
Q2 2021 | $2,059,000 | +325.4% | 145,200 | +391.7% | 0.00% | – |
Q1 2021 | $484,000 | -22.9% | 29,529 | -2.8% | 0.00% | – |
Q4 2020 | $628,000 | -72.3% | 30,365 | -43.8% | 0.00% | -100.0% |
Q1 2015 | $2,268,000 | -22.2% | 54,000 | -56.5% | 0.00% | -40.0% |
Q4 2014 | $2,916,000 | – | 124,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |